EU drug regulator to review Eli Lilly and Incyte arthritis drug for use in Covid-19 patients on oxygen ...News

The European Medicines Agency (EMA) said it will conduct an accelerated assessment of the arthritis drug Olumiant made by Eli Lilly and Incyte Corp to see if it can be rolled out to treat hospitalized Covid-19 patients on oxygen. The plan is to repurpose the drug for use in people over the age of 10 as a potential treatment to help reduce the inflammation and tissue damage associated with severe Covid-19 infections. The review will assess the results from two large randomized studies in patients being treated for the virus, the agency said in a statement on Thursday. Also on rt.com

Hence then, the article about eu drug regulator to review eli lilly and incyte arthritis drug for use in covid 19 patients on oxygen was published today ( Thursday 29/04/2021 - 08:48 PM ) and is available on Russia Today ( News ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( EU drug regulator to review Eli Lilly and Incyte arthritis drug for use in Covid-19 patients on oxygen )

Also on site :

• What’s known about the man charged with attempting to assassinate President Trump at the White House Correspondents’ Dinner
• European ‘propaganda’ using Russia as ‘external enemy’ to mask crises – Kremlin
• 9 Years Ago Today, a Hulu Series Based on a 1985 Dystopian Book Premiered — And It Changed Everything for Us!